Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB26FZRY3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,489
Award facts
- Contract value 100% obligated
- $12,489.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,489.26 to supply Kisqali 400 mg daily dose tablets in a quantity of 42 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 23, 2025, issued on October 22, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. Kisqali is a prescription oncology medication used in cancer treatment, reflecting the breadth of pharmaceutical products supplied through the Defense Logistics Agency's medical supply chain to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company is a major pharmaceutical distributor and healthcare solutions provider that consistently wins competitive federal awards, demonstrating capability to meet stringent federal procurement requirements across multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies for various government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB26FZRY3?
SPE2DB26FZRY3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FZRY3 worth?
The government has obligated $12,489 on SPE2DB26FZRY3.
Is contract SPE2DB26FZRY3 an order under another contract?
Yes. SPE2DB26FZRY3 is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB26FZRY3 competed?
The extent of competition for SPE2DB26FZRY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award